2nd Annual Innovation in Phase One Clinical Development (Innovation in Phase )
Venue: Aptuit (Verona) Srl.
|Event Date/Time: Sep 13, 2011||End Date/Time: Sep 14, 2011|
The proportion of clinical trials in phase I has increased significantly over recent years from 25% in 2001 to around 40% today. This coupled with the number of high profile phase III failures has put increased emphasis on making the right decision as early as possible. What strategies are you putting in place to prevent late stage failures?
Unlocking the potential of imaging, biomarkers and alternative trial designs has the power to greatly reduce the time and cost of your trial and speed time to market. With 16 industry experts, 2 regulators and 7 discussion and networking sessions providing a how to approach to implementing these techniques, Pharma IQ's 2nd Annual Innovation in Phase Clinical Development conference can't be missed!
The event takes place on 13-14 September 2011 and is the only event in Europe where you can hear directly from the MHRA about the new ICH S9 guidance.
Download the brochure all the details and full speaker line up.